Want to see BBOT full AI Analyst Report?
Technical Sentiment
Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting BridgeBio Oncology Therapeutics is a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 7.90, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 8.20, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Buy.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
7.56
7.80
8.11
8.35
8.66
8.90
9.21
Fibonacci
7.80
8.01
8.14
8.35
8.56
8.69
8.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
8.05Buy
8.10Buy
MA10
7.79Buy
7.94Buy
MA20
7.69Buy
7.90Buy
MA50
8.13Buy
8.20Buy
MA100
8.84Sell
8.85Sell
MA200
10.42Sell
9.82Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 7.94, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 8.85, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 8.13, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 8.84, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 10.42, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
56.29
Neutral
STOCH (9,6)
80.80
Sell
STOCHRSI (14)
80.80
Sell
MACD (12,26)
-0.02
Sell
ADX (14)
16.03
Buy
Williams %R
-25.09
Buy
CCI (14)
208.41
Sell
ATR (14)
0.52
-
Ultimate Oscillator
44.63
Neutral
ROC
7.24
Buy
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 56.29, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 16.03, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is 208.41, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is 7.24, creating a Buy signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Buy.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 56.29, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.02, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 8.05, which suggests BBOT is a Buy.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 7.69, which suggests BBOT is a Buy.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 8.13, which suggests BBOT is a Buy.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 10.42, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -25.09, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is 208.41, which suggests BBOT is a Sell.